Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-T: TachoSil in Esophageal Anastomoses
NCT02105506Completed
- Start
- Sep 2012
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tachosil in esophageal disease. Primary endpoint: Feasibility of TachoSil application. Started Sep 2012; status: completed.
02
Drugs
tachosil
03
Conditions
esophageal disease
Beyond the preview
Go deeper on NCT02105506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02105506.